Pfizer to ship 13 million doses of COVID-19 vaccine per week to the United States by mid-March, official says

(Reuters) – Pfizer Inc plans to deliver more than 13 million doses of its COVID-19 vaccine per week to the United States by mid-March, more than doubling its shipments from early February, a senior Pfizer executive said in a prepared testimony. of a congressional hearing on Tuesday.

Pfizer has shipped around 40 million doses to sites across the United States so far and is on track to deliver 120 million doses of its two-dose regimen by the end of March, said John Young, Commercial Director of Pfizer.

He added that Pfizer was also ready to deliver a total of 300 million doses to the United States by the end of July and raised global production expectations for 2021 to at least 2 billion doses.

In his own prepared remarks, Moderna Inc President Stephen Hoge said the drugmaker plans to deliver 100 million doses of its two-dose injection by the end of March and 300 million by the end of March. the end of July.

Johnson & Johnson believe they can ship at least 20 million doses of its single-dose injection to the United States by the end of March after receiving U.S. regulatory clearance, Vice President of Medical Affairs Richard Nettles said. It plans to ship 100 million doses by mid-2021, he said.

The drugmakers’ remarks put the United States on track to receive 240 million doses by the end of March, enough to inoculate 130 million Americans, and 700 million doses by mid-l year, more than enough to assay the entire American population.

The comments were prepared ahead of a U.S. Congressional hearing on vaccine availability to be held Tuesday by the House Committee on Energy and Commerce.